Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study.

Kubota K, Kamijima Y, Kao Yang YH, Kimura S, Chia-Cheng Lai E, Man KKC, Ryan P, Schuemie M, Stang P, Su CC, Wong ICK, Zhang Y, Setoguchi S.

PLoS One. 2018 Dec 12;13(12):e0208796. doi: 10.1371/journal.pone.0208796. eCollection 2018.

2.

Positive predictive value of ICD-10 codes for acute myocardial infarction in Japan: a validation study at a single center.

Ando T, Ooba N, Mochizuki M, Koide D, Kimura K, Lee SL, Setoguchi S, Kubota K.

BMC Health Serv Res. 2018 Nov 26;18(1):895. doi: 10.1186/s12913-018-3727-0.

3.

Comparative safety of NSAIDs for gastrointestinal events in Asia-Pacific populations: A multi-database, international cohort study.

Lai EC, Shin JY, Kubota K, Man KKC, Park BJ, Pratt N, Roughead EE, Wong ICK, Kao Yang YH, Setoguchi S.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1223-1230. doi: 10.1002/pds.4663. Epub 2018 Sep 19.

PMID:
30232832
4.

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.

Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, Bushnell G, Crystal S, Furu K, KaoYang YH, Karlstad Ø, Kieler H, Kubota K, Lai EC, Martikainen JE, Maura G, Moore N, Montero D, Nakamura H, Neumann A, Pate V, Pottegård A, Pratt NL, Roughead EE, Macias Saint-Gerons D, Stürmer T, Su CC, Zoega H, Sturkenbroom MCJM, Chan EW, Coghill D, Ip P, Wong ICK.

Lancet Psychiatry. 2018 Oct;5(10):824-835. doi: 10.1016/S2215-0366(18)30293-1. Epub 2018 Sep 13.

PMID:
30220514
5.

The use of anticoagulants in patients with non-valvular atrial fibrillation between 2005 and 2014: A drug utilization study using claims data in Japan.

Kubota K, Ooba N, Kamijima Y, Sato K, Koide D.

PLoS One. 2018 Sep 5;13(9):e0203380. doi: 10.1371/journal.pone.0203380. eCollection 2018.

6.

Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges.

Lai EC, Ryan P, Zhang Y, Schuemie M, Hardy NC, Kamijima Y, Kimura S, Kubota K, Man KK, Cho SY, Park RW, Stang P, Su CC, Wong IC, Kao YY, Setoguchi S.

Clin Epidemiol. 2018 Jul 27;10:875-885. doi: 10.2147/CLEP.S149961. eCollection 2018.

7.

Prevalence of Therapeutic Drug Monitoring for Lithium and the Impact of Regulatory Warnings: Analysis Using Japanese Claims Database.

Ooba N, Tsutsumi D, Kobayashi N, Hidaka S, Hayashi H, Obara T, Satoh M, Kubota K, Fukuoka N.

Ther Drug Monit. 2018 Apr;40(2):252-256. doi: 10.1097/FTD.0000000000000483.

8.

Post-marketing surveillance in Japan: Potential best way forward.

Hiroi S, Kubota K, Mishiro I, Fernandez JL.

Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1138-1139. doi: 10.1002/pds.4290. No abstract available.

PMID:
28913964
9.

Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening.

Ooba N, Setoguchi S, Sato T, Kubota K.

BMJ Open. 2017 Jun 30;7(6):e015935. doi: 10.1136/bmjopen-2017-015935.

10.

Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.

Roughead EE, Chan EW, Choi NK, Griffiths J, Jin XM, Lee J, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Nguyen TA, Ooba N, Park BJ, Sato T, Shin JY, Wang T, Wong IC, Yang YK, Pratt NL.

Expert Opin Drug Saf. 2016 Dec;15(12):1589-1595. Epub 2016 Sep 27.

PMID:
27645304
11.

Symmetry analysis for monitoring safety of newly marketed drugs.

Kubota K.

Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):349-51. doi: 10.1002/pds.3886. Epub 2015 Oct 6.

PMID:
26440748
12.

Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries.

Roughead EE, Chan EW, Choi NK, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Nguyen TA, Ooba N, Park BJ, Sato T, Shin JY, Wang T, Griffiths J, Wong IC, Yang YH, Pratt NL.

Drug Saf. 2015 Sep;38(9):823-31. doi: 10.1007/s40264-015-0318-4.

13.

Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network Approach.

Lai EC, Man KK, Chaiyakunapruk N, Cheng CL, Chien HC, Chui CS, Dilokthornsakul P, Hardy NC, Hsieh CY, Hsu CY, Kubota K, Lin TC, Liu Y, Park BJ, Pratt N, Roughead EE, Shin JY, Watcharathanakij S, Wen J, Wong IC, Yang YH, Zhang Y, Setoguchi S.

Epidemiology. 2015 Nov;26(6):815-20. doi: 10.1097/EDE.0000000000000325.

PMID:
26133022
14.

Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries.

Pratt N, Chan EW, Choi NK, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Ooba N, Park BJ, Sato T, Shin JY, Wong IC, Kao Yang YH, Roughead EE.

Pharmacoepidemiol Drug Saf. 2015 Aug;24(8):858-64. doi: 10.1002/pds.3780. Epub 2015 Apr 22.

15.

Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan.

Yamamoto M, Kubota K, Okazaki M, Dobashi A, Hashiguchi M, Doi H, Suka M, Mochizuki M.

Patient Prefer Adherence. 2015 Jan 23;9:173-84. doi: 10.2147/PPA.S75761. eCollection 2015.

16.

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database.

Kubota K, Kamijima Y, Sato T, Ooba N, Koide D, Iizuka H, Nakagawa H.

BMJ Open. 2015 Jan 14;5(1):e006450. doi: 10.1136/bmjopen-2014-006450.

17.

Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individuals.

Hayashi T, Kubota K, Kawashima S, Sone H, Watanabe H, Ohrui T, Yokote K, Takemoto M, Araki A, Noda M, Noto H, Sakuma I, Yoshizumi M, Ina K, Nomura H; Japan CDM group.

Int J Cardiol. 2014 Dec 20;177(3):860-6. doi: 10.1016/j.ijcard.2014.10.093. Epub 2014 Nov 5.

PMID:
25466567
18.

A prospective stratified case-cohort study on statins and multiple adverse events in Japan.

Ooba N, Sato T, Wakana A, Orii T, Kitamura M, Kokan A, Kurata H, Shimodozono Y, Matsui K, Yoshida H, Yamaguchi T, Kageyama S, Kubota K.

PLoS One. 2014 May 8;9(5):e96919. doi: 10.1371/journal.pone.0096919. eCollection 2014.

19.

Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.

Ina K, Hayashi T, Araki A, Kawashima S, Sone H, Watanabe H, Ohrui T, Yokote K, Takemoto M, Kubota K, Noda M, Noto H, Ding QF, Zhang J, Yu ZY, Yoon BK, Nomura H, Kuzuya M; Japan CDM Group.

Geriatr Gerontol Int. 2014 Oct;14(4):806-10. doi: 10.1111/ggi.12168. Epub 2013 Nov 12.

PMID:
24215618
20.

Temporal relationship between multiple drugs and multiple events in patient reports on adverse drug reactions: findings in a pilot study in Japan.

Kubota K, Okazaki M, Dobashi A, Yamamoto M, Hashiguchi M, Horie A, Inagaki A, Kikuchi T, Mochizuki M.

Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1134-7. doi: 10.1002/pds.3490. No abstract available.

PMID:
24092565

Supplemental Content

Loading ...
Support Center